官方服务：
资源简介：
RCT = randomized controlled trial, RBZ = ranibizumab, RBZ + Laser = ranibizumab combined with laser.Characteristics of Included Studies.
应用场景：
创建时间：
2015-12-02
相关数据集
Supplementary Material for: Cotton Wool Spots after Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Associated with Central Retinal Vein Occlusion
Purpose: To report a case series, whereby we encountered a transient increase in retinal cotton wool spots (CWS) following anti-vascular endothelial growth factor (anti-VEGF) therapy for
DataCite Commons2020-09-03 更新100
Supplementary Material for: The Association Between Retinal Thickness Fluctuations and Visual Outcomes Under Anti-VEGF Therapy: A Systematic Review and Meta-Analysis
Introduction: To examine the association between retinal thickness (RT) fluctuations and best-corrected visual acuity (BCVA) in eyes with neovascular AMD, macular edema secondary to RVO, and DME treat
DataCite Commons2025-06-01 更新70
Supplementary Material for: Repeat Intravitreal Bevacizumab in a Very Low Birth Weight Infant with Recurrent ROP: 3-Year Follow-Up and Literature Review
Purpose: Low gestational birth weight is associated with increased incidence of Retinopathy of Prematurity (ROP). In recent years, intravitreal injection of anti-vascular endothelial growth factor (VE
DataCite Commons2025-06-13 更新50
Supplementary Material for: Evaluation of the First-dose Anti-VEGF Anatomical Response in Polypoidal Choroidal Vasculopathy Patients: Correlation with the Third-dose Response and Risk Factors Analysis
Introduction: To investigate whether first-dose efficacy can predict third-dose anatomical response and analyze the risk factors for first-dose response of polypoidal choroidal vasculopathy (PCV) pati
DataCite Commons2024-12-21 更新70
Aqueous Flare after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Drugs in Neovascular Age-Related Macular Degeneration
Aqueous flare values in patients with neovascular age-related macular degeneration (nAMD) receiving anti-vascular endothelial growth factor (VEGF) therapy, including brolucizumab. This retrospe
DataCite Commons2025-06-26 更新50
